Why is Syncom Formul. falling/rising?

As of 23-Sep, Syncom Formulations (India) Ltd is experiencing a decline in its stock price, currently at 17.41, which reflects a decrease of 0.15 or 0.85%. The stock has underperformed its sector by 0.5% today and has been on a downward trend for the last three days, accumulating a total loss of 3.65%. In terms of longer-term performance, the stock has seen a significant decline of 21.08% over the past year, despite reporting positive results for the last five consecutive quarters, including a 64.23% growth in net sales over the latest six months. However, the company faces challenges with poor long-term growth metrics, including a staggering annual decline in net sales of 63.92% over the last five years, which contributes to its current negative price movement.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has underperformed the Sensex, which has only fallen by 0.34% over the past week. While the stock has shown some resilience with a 0.23% increase over the past month, its year-to-date performance remains concerning with a decline of 12.95%, compared to the Sensex's gain of 5.07%. The lack of domestic mutual fund investment, which stands at 0%, suggests a lack of confidence in the stock's valuation, especially given its high Price to Book Value ratio of 4.8 compared to peers. This combination of factors indicates that while there are some positive aspects to the company's recent performance, the overall sentiment remains negative, contributing to the stock's decline.